Literature DB >> 18354105

Acinetobacter infection.

L Silvia Munoz-Price1, Robert A Weinstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354105     DOI: 10.1056/NEJMra070741

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  213 in total

1.  Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity.

Authors:  Jason W Sahl; J Kristie Johnson; Anthony D Harris; Adam M Phillippy; William W Hsiao; Kerri A Thom; David A Rasko
Journal:  BMC Genomics       Date:  2011-06-04       Impact factor: 3.969

2.  Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii.

Authors:  Mark D Adams; E Ricky Chan; Neil D Molyneaux; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

3.  fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

Authors:  Rajesh V Dudhani; John D Turnidge; Roger L Nation; Jian Li
Journal:  J Antimicrob Chemother       Date:  2010-06-23       Impact factor: 5.790

4.  A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla(OXA-23) gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii.

Authors:  Yangsoon Lee; Chang-Ki Kim; Hyukmin Lee; Seok Hoon Jeong; Dongeun Yong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

5.  Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination.

Authors:  Chunmei Ying; Yongli Li; Yaping Wang; Bing Zheng; Chengde Yang
Journal:  J Antibiot (Tokyo)       Date:  2015-04-15       Impact factor: 2.649

6.  Morbidity and mortality risk factors in emergency department patients with Acinetobacter baumannii bacteremia.

Authors:  Rui-Xue Sun; Priscilla Song; Joseph Walline; He Wang; Ying-Chun Xu; Hua-Dong Zhu; Xue-Zhong Yu; Jun Xu
Journal:  World J Emerg Med       Date:  2020

7.  Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

8.  Rapid determination of quinolone resistance in Acinetobacter spp.

Authors:  Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Jodi M Thomson; Mark D Adams; Karrie Goglin; Philip N Rather; Thuy-Trang D Pennella; Christian Massire; Mark W Eshoo; Rangarajan Sampath; Lawrence B Blyn; David J Ecker; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

9.  Multidrug-resistant Acinetobacter baumannii in New York City - 10 years into the epidemic.

Authors:  Daniel J Morgan; Scott A Weisenberg; Michael H Augenbraun; David P Calfee; Brian P Currie; E Yoko Furuya; Robert Holzman; Marisa C Montecalvo; Michael Phillips; Bruce Polsky; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2009-02       Impact factor: 3.254

10.  Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period.

Authors:  Lei Huang; Liying Sun; Yan Yan
Journal:  J Microbiol       Date:  2013-03-02       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.